Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Development of a Biosensor for Anthrax Therapeutics and Diagnostics

---
identifier: "/us/fr/05-12308"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Development of a Biosensor for Anthrax Therapeutics and Diagnostics"
title_number: 0
title_name: "Federal Register"
section_number: "05-12308"
section_name: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Development of a Biosensor for Anthrax Therapeutics and Diagnostics"
positive_law: false
currency: "2005-06-22"
last_updated: "2005-06-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "05-12308"
document_type: "notice"
publication_date: "2005-06-22"
agencies:
  - "Defense Department"
  - "Army Department"
fr_citation: "70 FR 36128"
fr_volume: 70
fr_action: "Notice"
---


#  Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Development of a Biosensor for Anthrax Therapeutics and Diagnostics

**AGENCY:**

Department of the Army, DoD.

**ACTION:**

Notice

**SUMMARY:**

In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 60/653,230 entitled “Development of a Biosensor for Anthrax Therapeutics and Diagnostics, filed February 14, 2005. The United States Government, as represented by the Secretary of the Army, has rights in this invention.

**ADDRESSES:**

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

**FOR FURTHER INFORMATION CONTACT:**

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

**SUPPLEMENTARY INFORMATION:**

This biosensor can be used for several different purposes namely: (1) Study toxin protein-protein interactions; (2) Screen anthrax therapeutic molecules such as antibodies and small molecules; (3) As a diagnostic tool to detect anthrax toxins in blood or urine samples.

Brenda S. Bowen

Army Federal Register Liaison Officer.